Latest Mesoblast News & Updates
See the latest news and media coverage for Mesoblast. We track all announcements, press releases, and industry mentions in real time, all in one place.
Commercial-stage biotechnology company developing mesenchymal lineage cell therapies
mesoblast.com- Headquarters
- Melbourne, Australia
- Founded year
- 2004
- Company type
- Public company
- Number of employees
- 100–200
Latest news about Mesoblast
Company announcements
-
Mesoblast reports Ryoncil net revenues of US$30.3m
Net operating cash spend improves to US$4.1 million for the quarter.
-
Mesoblast releases quarterly activities and cash flow report
Report issued on April 30, 2026. Available as PDF download.
-
Mesoblast achieves patient recruitment target in CLBP pivotal trial
Recruitment target is reached for the pivotal trial in chronic low back pain.
-
Mesoblast acquires CAR platform
The acquisition enhances cell products with precision capabilities. Announced April 15, 2026.
Media coverage
-
Mesoblast Reports Ryoncil® Net Revenues of US$30.3m and Improved Net Operating Cash Spend for the Quarter to US$4.1 Million
Achieved Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain Activity Report for Quarter Ended March 31, 2026 (Appendix 4C) NEW...
-
Mesoblast Ltd (MESO): Secure Exclusive Rights to a Vital Platform
Mesoblast Ltd (NASDAQ:MESO) is among the best Australian stocks to buy in 2026. On April 14, Mesoblast Ltd (NASDAQ:MESO) announced that it has secured exclusive...
-
Mesoblast completes enrollment in back pain therapy trial By Investing.com
Mesoblast Limited (NASDAQ:MESO; ASX:MSB) announced Monday that its Phase 3 clinical trial evaluating rexlemestrocel-L for chronic low back pain associated with degenerative disc disease has...
-
Mesoblast Issues 3.28 Million New Shares on Option Conversions
Detailed price information for Mesoblast Ltd Ord (MEOBF) from The Globe and Mail including charting and trades.
Track Mesoblast and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Mesoblast competitors & trending companies
Browse news for competitors to Mesoblast and other trending companies.
NextCell Pharma
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy
Nordan AI
Mips
Vexlum
Asker Healthcare Group